Wendy E. McDermott - 03 Jan 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Human Resources
Signature
/s/ Wendy E. McDermott
Issuer symbol
LXRX
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 20:34:27 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +85,185 $0.000000 85,185 03 Jan 2022 Common Stock 85,185 $3.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (1/3/2023) and vests 1/48th per month for each month of service thereafter.